Blank, Christian and Kuball, J and Voelkl, S and Wiendl, H and Becker, B and Walter, B and Majdic, O and Gajewski, TF and Theobald, M and Andreesen, R and Mackensen, A (2006) Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro. INTERNATIONAL JOURNAL OF CANCER, 119 (2). pp. 317-327. ISSN 0020-7136,
Full text not available from this repository. (Request a copy)Abstract
Human tumors frequently escape immune destruction, despite the presence of cyototoxic T cells (CTL) recognizing tumor-associated antigens (TAA). We have previously shown that programmed death ligand-1 (PD-L1), a recently identified ligand of the B7 superfamily, is expressed on murine tumors and can inhibit antitumor immune responses. To evaluate the clinical relevance of our animal model findings, we examined human tumors and tumor-specific T cells. We found PD-L1 to be constitutively expressed on human renal cell carcinoma (RCC) cell lines and upregulated on human melanoma cell lines upon exposure to interferon-gamma. Similarly, we found binding of anti-PD-L1 monoclonal antibody (mAb) on frozen sections from RCC and melanomas, but not on normal tissues. The corresponding inhibitory receptor of PD-L1, PD-1, revealed a higher expression on tumor-infiltrating lymphocytes than on peripheral blood lymphocytes (PBL) from melanoma patients upon specific antigen stimulation. Stimulation of PBL from healthy donors with peptide-loaded dendritic cells in the presence of anti-PD-L1 mAb altered neither the total T cell numbers after expansion, nor the percentage of peptide-specific CTL, when providing a T cell help by addition of cytokines. However, when stimulating TAA-specific CTL and T helper cells with Ag-pulsed dendritic cells in the absence of exogenous cytokines, PD-L1 blockade increased the cytokine production. Similar to the data achieved in the marine system, the blockade of PD-L1 on human tumors resulted in enhanced cytolytic activity of TAA-specific CTLs and cytokine production of TAA-specific T helper cells when interacting directly with the tumor. In summary, our data suggest that PD-L1/PD-1 interactions negatively regulate T cell effector functions predominately in the absence of exogenous cytokine support, indicating an important role for this pathway in tumor evasion. (c) 2006 Wiley-Liss, Inc.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | PERIPHERAL-BLOOD LYMPHOCYTES; COLONY-STIMULATING FACTOR; PROGRAMMED DEATH-1; ADOPTIVE TRANSFER; DENDRITIC CELLS; B7 FAMILY; INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; PHASE-I; POTENTIAL MECHANISM; RCC; PD-L1; PD-1; B7-H1; melanoma |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Dermatologie und Venerologie Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) Medicine > Lehrstuhl für Urologie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 10 Feb 2021 06:45 |
| Last Modified: | 10 Feb 2021 06:45 |
| URI: | https://pred.uni-regensburg.de/id/eprint/34299 |
Actions (login required)
 |
View Item |
